Home › Burkitt Lymphoma › Georgia › Atlanta

Pag-aaral pangklinika para sa Burkitt Lymphoma sa Atlanta, GA

Isang pag-aaral para sa Burkitt Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Atlanta. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 2

Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta

366 Days – 46 Years · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Nagre-recruitPhase 3

Emory University Hospital/Winship Cancer Institute, Atlanta

Edad 18 hanggang 39 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT03150693

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral

Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Nagre-recruitPhase 2

Emory University Hospital/Winship Cancer Institute, Atlanta
Emory Saint Joseph's Hospital, Atlanta

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Nagre-recruitPhase 2

Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta

365 Days · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06317662

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 1

Winship Cancer Institute Emory University, Atlanta
Northside Hospital Cancer Institute, Atlanta

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT03666000

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 2

Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta

Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Nagre-recruitPhase 3

Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta

365 Days – 25 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03959085

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Nagre-recruitPhase 1/2

Research Site, Atlanta

Edad 12 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT06137118

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Nagre-recruitPhase 2

Children's Healthcare of Atlanta at Egleston, Atlanta

Edad 7 hanggang 25 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05082519

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Nagre-recruitPhase 1

Winship Cancer Institute, Emory University, Atlanta

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2025 · NCT04260022

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Nagre-recruitPhase 2

Children's Healthcare of Atlanta, Atlanta

Edad 1 hanggang 25 · Lahat ng kasarian · Na-update May 4, 2025 · NCT03509961

Pag-aaral para sa Burkitt Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Atlanta

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.